Summary
Oxidative metabolism of estrogens has been associated with genotoxicity.O-methylation of catechol estrogens is considered as a protective mechanism.4-Methoxyequilenin (4-MeOEN) is the O-methylated product of 4-hydroxyequilenin(4-OHEN). 4-OHEN, the major catechol metabolite of the equine estrogens present inthe most widely prescribed hormone replacement therapeutics, causes DNA damagevia quinone formation. In this study, estrogen receptor (ERα) binding of 4-MeOENwas compared with estradiol (E2) and equilenin derivatives including 4-BrEN usingcomputer modeling, estrogen response element (ERE)-luciferase induction in MCF-7cells, and alkaline phosphatase (AP) induction in Ishikawa cells. 4-MeOEN inducedAP and luciferase with nanomolar potency and displayed a similar profile of activityto E2. Molecular modeling indicated that MeOEN could be a ligand for ERα despiteno binding being observed in the ERα competitive binding assay. Methylationof 4-OHEN may not represent a detoxification pathway, since 4-MeOEN is a fullestrogen agonist with nanomolar potency.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Colditz GA (1998) Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J. Natl. Cancer Inst., 90: 814–823.
Service, RF (1998) New role for estrogen in cancer? Science, 279: 1631–1633.
Grady D, Gebretsadik T, Kerlikowske, et al. (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol., 85: 304–313.
Liehr JG (1990) Genotoxic effects of estrogens. Mutation Res., 238: 269–276.
Santen RJ (2002) To block estrogen’s synthesis or action: that is the question. J. Clin. Endocrinol. Metab., 87: 3007–3012.
Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis, 19: 1–27.
Zhu BT, Liehr JG (1996) Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J. Biol. Chem., 271: 1357–1363.
Zhang F, Chen Y, Pisha E, et al. (1999) The major metabolite of equilin, 4-hydroxyequilin autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone. Chem. Res. Toxicol., 12: 204–213.
Spink DC, Zhang F, Hussain MM, et al. (2001) Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells. Chem. Res. Toxicol., 14: 572–581.
Yao J, Li Y, Chang M, et al. (2003) Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase. Chem. Res. Toxicol., 16: 668–675.
Liu X, Yao J, Pisha E, et al. (2002) Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha. Chem. Res. Toxicol., 15: 512–519.
Rao PN, Somawardhana CW (1987) Synthesis of 2-methoxy and 4-methoxy equine estrogens. Steroids, 49: 419–432.
Liu X, Zhang F, Liu H, et al. (2003) Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin. Chem. Res. Toxicol., 16: 741–749.
Catherino WH, Jordan VC (1995) Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue. Cancer Lett., 92: 39–47.
Pisha E, Pezzuto JM (1997) Cell-based assay for the determination of estrogenic and anti-estrogenic activities. Methods Cell Sci., 19: 37–43.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Chang, M. et al. (2008). Estrogenic Activity of the Equine Estrogen Metabolite, 4-Methoxyequilenin. In: Li, J.J., Li, S.A., Mohla, S., Rochefort, H., Maudelonde, T. (eds) Hormonal Carcinogenesis V. Advances in Experimental Medicine and Biology, vol 617. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69080-3_62
Download citation
DOI: https://doi.org/10.1007/978-0-387-69080-3_62
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-69078-0
Online ISBN: 978-0-387-69080-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)